|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM INCOME
STATEMENT, BALANCE SHEET AND CASH FLOW AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0001068874
<NAME> IMPLANT SCIENCES
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 3,123,723
<SECURITIES> 0
<RECEIVABLES> 756,643
<ALLOWANCES> 14,602
<INVENTORY> 200,378
<CURRENT-ASSETS> 4,292,720
<PP&E> 4,617,380
<DEPRECIATION> 1,200,133
<TOTAL-ASSETS> 7,990,897
<CURRENT-LIABILITIES> 874,660
<BONDS> 0
0
0
<COMMON> 580,627
<OTHER-SE> 6,129,037
<TOTAL-LIABILITY-AND-EQUITY> 7,990,897
<SALES> 854,405
<TOTAL-REVENUES> 854,405
<CGS> 1,790,758
<TOTAL-COSTS> 1,790,758
<OTHER-EXPENSES> 1,981
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 59,726
<INCOME-PRETAX> (878,606)
<INCOME-TAX> 0
<INCOME-CONTINUING> (878,606)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (878,606)
<EPS-BASIC> (0.15)
<EPS-DILUTED> (0.15)
</TABLE>
|
|